Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on May 5, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NMCSD Blood and Blood Products

Closed
HT941025N0083Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621991
Federal
Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.
Solicitation # 0012468284
The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.
W40M MRC0 West

POSTED

9 days ago

DEADLINE

in 2 days
NAICS: 621991
Federal
6505--Human Blood and Blood Products
Solicitation # 36C25727Q0049
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.
257-NETWORK Contract Office 17 (36C257)

POSTED

13 days ago

DEADLINE

in 8 days
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.
National Institutes Of Health

POSTED

14 days ago

DEADLINE

in 4 months
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

14 days ago

DEADLINE

in 4 months
NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

3 months ago

DEADLINE

in 9 months

AI Contract Overview

Show more

The Defense Health Agency Contracting Activity (DHACA), Western Healthcare Operations Contracting Division intends to award a sole source, firm fixed-price Blanket Purchase Agreement to San Diego Blood Bank (SDBB) for the supply of blood and blood products, including red blood cells, fresh frozen plasma, pooled cryoprecipitate, and other derivatives from whole blood for use at the Naval Medical Center San Diego (NMCSD). The agreement will have a 5-year ordering period, running from September 1, 2025, to August 31, 2030. This procurement follows the Federal Acquisition Regulation allowing sole source acquisitions where only one supplier can meet urgent needs. Based on market research and past procurement history, SDBB is identified as the only vendor capable of providing rotational, on-demand, and urgent deliveries required by NMCSD, including fulfilling STAT orders within four hours. The contract is classified under NAICS code 621991 for Blood and Organ Banks and PSC code 6550 for In Vitro Diagnostics Substances. It is not open for competitive bids; however, the notice allows interested vendors to submit capability statements by May 14, 2025, for consideration. These submissions will be evaluated solely to determine if a competitive process is feasible. The contract underscores the critical requirement for continuous and immediate access to specialized blood and blood product supplies, which SDBB is uniquely positioned to provide to NMCSD based on location and capabilities. All correspondence regarding challenges or submissions must be directed via email—telephone inquiries are not accepted.

General Info

Five-year sole source contract awarded to San Diego Blood Bank for urgent blood supply at Naval Medical Center.

NAICS

621991 - Blood and Organ Banks

Place of Performance

San Diego, CA, 92102, USA

Set-Aside

NONE

Documents

1

Notice of Intent to Sole Source HT941025N0083

PDF, Low prioritynotice-of-intent
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseClosed
Posted

special-notice

Notice updated

The notice description changed. The point of contact changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DEFENSE HEALTH AGENCY (DHA)
Contacts2 people available
OfficeFALLS CHURCH, VA, 22042, USA
Office AddressFALLS CHURCH, VA, 22042, USA
Contacts
CHA-ON Gordon
Tracy Robinson

Full Description

Show more

Notice of Intent to Sole Source


 HT941025N0083


THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SERVICE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Western Healthcare Operations Contracting Division (WHOCD), intends to award a firm fixed price supply Blanket Purchase Agreement for Blood and Blood Products for use in the Naval Medical Center San Diego (NMCSD), in accordance with the Federal Acquisition Regulation (FAR) 13.501(a) Sole Source acquisitions and FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to:



San Diego Blood Bank (SDBB)


3636 Gateway Center Ave Ste 100


San Diego, CA 92102-4508


+1 (555) 000-0000


UEI: M9V6X54L11X7 CAGE: 1JRY9



The North American Industry Classification System (NAICS) code for this requirement is 621991 – Blood and Organ Banks; the business size standard is $40 million. The Product Service Code (PSC) is 6550 – In Vitro Diagnostics Substances, Reagents, Test Kits, and Sets.



The objective of this sole source Blanket Purchase Agreement (BPA) is to establish a 5-year ordering period a supply of Red Blood Cells, fresh frozen plasma, pooled cryoprecipitate, and other products made or derived from whole blood for the Naval Medical Center San Diego (NMCSD). To maintain its services, NMCSD Laboratory must always have blood products on the shelf and must deliver STAT orders within four hours of request. Additionally, laboratory requires referral testing as needed.



Ordering Periods: 1 September 2025 to 31 August 2030


Delivery Address: Naval Medical Center San Diego (NMCSD), California


34800 Bob Wilson Drive, San Diego, CA 92134


Based on market research and previous acquisition history, it has been determined that San Diego Blood Bank UEI: M9V6X54L11X7 CAGE: 1JRY9 is the only vendor capable meeting the needs of the Government. San Diego Blood Bank UEI: M9V6X54L11X7 CAGE: 1JRY9 is the only supplier able to quickly supply Naval Medical Center San Diego (NMCSD) on a rotational basis.  The suggested source, SDBB is the only supplier able to quickly supply NMCSD on a rotational basis for packed red cells, platelets, plasma and cryo, and other blood products on an urgent and as needed basis. Based on market research and previous acquisition history, it has been determined that this requirement shall be Sole Sourced to San Diego Blood Bank UEI: M9V6X54L11X7 CAGE: 1JRY9 under the NAICS code 621991 and PSC 6505.



This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability.



Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.



If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Cha-on P. Gordon at contact@example.gov.



The closing date for challenges is no later than 1300 Pacific Daylight Time, Wednesday 14 May 2025.



NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

More opportunities from Department Of Defense → DEFENSE HEALTH AGENCY (DHA)

Same awarding agency

NAICS: 561910
New
Federal
DHA - Offsite Sterile Processing Support Services
Solicitation # HT9427-27-RFI-0001
The Defense Health Agency (DHA) is conducting market research through a Request for Information (RFI) to identify qualified contractors capable of providing offsite sterile processing (SPD) support for various Military Treatment Facilities (MTFs). The primary goal is to enhance service resilience and workload stability by outsourcing the decontamination, assembly, and sterilization of surgical instruments, including minimally invasive surgical cases, power equipment, and Da Vinci accessories. The scope of work requires the contractor to manage the entire logistics chain, including providing transport containers and ensuring the secure, environmentally controlled transportation of contaminated instruments to offsite facilities and the return delivery of sterile inventory. This effort covers numerous MTFs across the United States, with specific critical locations designated as requiring no interruptions in service. Potential providers must adhere to rigorous industry and federal standards, including ANSI/AAMI ST79 and ST58, FDA 21 CFR Part 820, and various OSHA and DOT regulations. While the government has provided a general planning estimate of approximately 2,000 trays per month, final contract terms, award structures, and small business set-aside determinations will be decided based on the capabilities and feedback received from industry respondents. This is strictly a fact-finding mission and does not constitute a formal solicitation or an obligation to award a contract.
Packaging and Labeling Services

POSTED

6 days ago

DEADLINE

in 9 days
View Details
NAICS: 541715
Federal
DHA Enterprise-Wide Commercial Solutions Opening (CSO)
Solicitation # HT003826SC005
The Defense Health Agency (DHA) has established the Enterprise-Wide Commercial Solutions Opening (CSO), solicitation number HT003826SC005, to identify and acquire commercial products, services, and non-developmental items. Active from August 7, 2026, through August 6, 2027, this initiative seeks commercially available capabilities that can be deployed immediately or modified to meet DHA requirements across its Medical Digital Solutions, Medical Services, and Medical Products portfolios. The government will utilize a variety of award vehicles, including firm-fixed-price FAR-based contracts and Other Transaction (OT) agreements for research, prototyping, and experimental purposes under authorities such as 10 U.S.C. 3458, 3201, 4021, 4022, and 4023. The procurement process is driven by the issuance of specific Areas of Interest (AoI), which define problem statements, objectives, and submission criteria. Submissions undergo a streamlined, multi-phase evaluation process: Phase I involves a pitch or white paper evaluated on a Go/No-Go basis for strategic alignment and feasibility; Phase II may include an optional oral presentation or demonstration to assess technical viability; and Phase III requires a full commercial proposal evaluated on technical merit, cost reasonableness, and past performance. This CSO is administered by the DHACA Defense Healthcare Management Systems Contracting Division and is designed to prioritize cost-effective, commercially viable solutions to enhance healthcare readiness and patient safety.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

28 days ago

DEADLINE

N/A
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS